Prospects of the Use of Cell Therapy to Induce Immune Tolerance

Front Immunol. 2020 May 12:11:792. doi: 10.3389/fimmu.2020.00792. eCollection 2020.

Abstract

Conditions in which abnormal or excessive immune responses exist, such as autoimmune diseases (ADs), graft-versus-host disease, transplant rejection, and hypersensitivity reactions, are serious hazards to human health and well-being. The traditional immunosuppressive drugs used to treat these conditions can lead to decreased immune function, a higher risk of infection, and increased tumor susceptibility. As an alternative therapeutic approach, cell therapy, in which generally intact and living cells are injected, grafted, or implanted into a patient, has the potential to overcome the limitations of traditional drug treatment and to alleviate the symptoms of many refractory diseases. Cell therapy could be a powerful approach to induce immune tolerance and restore immune homeostasis with a deeper understanding of immune tolerance mechanisms and the development of new techniques. The purpose of this review is to describe the current panoramic scope of cell therapy for immune-mediated disorders, discuss the advantages and disadvantages of different types of cell therapy, and explore novel directions and future prospects for these tolerogenic therapies.

Keywords: autoimmune diseases; cell therapy; immune homeostasis; immune reconstitution; immune tolerance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy*
  • Autoimmunity
  • Graft Rejection / immunology
  • Graft Rejection / therapy
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / therapy
  • Homeostasis / immunology*
  • Humans
  • Hypersensitivity / immunology
  • Hypersensitivity / therapy
  • Immune Tolerance*
  • Immunotherapy, Adoptive / methods*
  • Mice
  • Stem Cell Transplantation / methods*
  • Vaccination / methods*